|
|
|
06-16-2011, 10:42 PM
|
#4471 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
The New York Stem Cell Foundation Announces: Inaugural NYSCF – Robertson Neuroscience Investigator Awards RFA and The 2011 NYSCF – Robertson Stem Cell Investigator RFA
The New York Stem Cell Foundation Expands Efforts to Foster Transformative Research New York, NY (PRWEB) June 16, 2011 In its ongoing efforts to cultivate the next generation of innovative scientific researchers, The New York Stem Cell Foundation (NYSCF) announced details and the RFA for the new NYSCF – Robertson Neuroscience Investigator Awards as well as the RFA for the second year of NYSCF – Robertson Stem Cell Investigator Awards. The new NYSCF Neuroscience Investigator Program is designed to foster truly innovative and excellent neuroscience with the potential to transform our fundamental understanding of the brain and how it functions. NYSCF – Robertson Neuroscience Investigators will work on a broad spectrum of developmental, cellular, cognitive and behavioral neuroscience (which need not be related to stem cells). At least nine NYSCF – Robertson Investigators will receive awards in the first three years. The NYSCF – Robertson Stem Cell Investigator Awards promote research exploring the therapeutic potential of human stem cells. At least 18 NYSCF – Robertson Stem Cell Investigators will be awarded in the first five years, of which the inaugural group was awarded in 2010. All NYSCF - Robertson Investigators will receive $1.5 million over five years with the program awarding over $40 million to support scientists in the next stages of their careers. All candidates must be within five years of starting as a tenure track professor or comparable position. read.... http://www.prweb.com/releases/2011/6/prweb8577346.htm |
|
|
|
06-20-2011, 12:12 PM
|
#4472 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Using Stem Cells To Grow Organs
Posted on: Monday, 20 June 2011, 07:50 CDT Researchers have discovered a technique that allows rat stem cells, injected into mice to create suitable organs for the mice. Lead researcher Professor Hiromitsu Nakauchi, director of the center for stem cell biology and regenerative medicine at the University of Tokyo in Japan, told the Telegraph: “Our ultimate goal is to generate human organs from induced pluripotent stem cells. “The technique, called blastocyst complementation, provides us with a novel approach for organ supply. We have successfully tried it between mice and rats. We are now rather confident in generating functional human organs using this approach.” Presenting the study at the annual conference of the European Society of Human Genetics, Professor Nakauchi used a type of adult stem cell known as induced pluripotent stem cells, which can be taken from a sample of tissue such as the skin and encouraged to grow into any type of cell found in the body. more... http://www.redorbit.com/news/health/...ans/index.html |
|
|
|
|
06-20-2011, 12:14 PM
|
#4473 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Stem Cell Partnership In Lebanon Announced
Amni BioScience, SAL announced today the formal signing of a long-term agreement with Clinique Du Levant Société Médicale SAL in Beirut, Lebanon. This agreement will initiate a wide array of therapies involving the use of adult stem cell products as manufactured by Stemedica Cell Technologies under FDA (United States Federal Drug Administration) approval. Beirut, Lebanon (PRWEB) June 20, 2011 Amni BioScience, SAL (“AMNI”) announced today the formal signing of a long-term agreement with Clinique Du Levant Société Médicale SAL (“LEVANT”) in Beirut, Lebanon. This agreement will initiate a wide array of therapies involving the use of adult stem cell products as manufactured by Stemedica Cell Technologies under FDA (United States Federal Drug Administration) approval. In order to maximize the rapidly expanding research and clinical application opportunities available within the fields of restorative and regenerative medicine, AMNI and LEVANT plan on playing a critical role in the full evolution of the most advanced regenerative-based therapies and services. “We’re honored to be working with a facility with the kind of outstanding leadership as LEVANT”, said Amni BioScience President Mr. Sam Alkhass. “Together, we plan on becoming a world leader in the fields of restorative and regenerative medicine.” read... http://www.prweb.com/releases/2011/6/prweb8583597.htm |
|
|
|
|
06-20-2011, 02:08 PM
|
#4474 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
First Prosthetic Bypass Graft Performed By University Of Louisville Surgeons Using Patient's Stem Cells
Main Category: Vascular Also Included In: Stem Cell Research; Clinical Trials / Drug Trials Article Date: 19 Jun 2011 - 2:00 PDT The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, reports the University of Louisville surgeon who is the principal investigator. The "TGI-PVG IDE" clinical trial initiated at UofL involves using a patient's own stem cells to line man-made bypass grafts to better the chances at saving the limbs of patients with peripheral artery disease. Charles B. Ross, M.D., chief of the Division of Vascular Surgery and Endovascular Therapeutics, is principal investigator and is joined by Marvin E. Morris, M.D., Amit J. Dwivedi, M.D. and Stuart Williams, Ph.D. read... http://www.medicalnewstoday.com/releases/228955.php |
|
|
|
|
06-21-2011, 09:34 PM
|
#4475 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Reportlinker Adds The Stem Cell Market Outlook
Jun 21 05:57 AM US/Eastern NEW YORK, June 21, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue: The Stem Cell Market Outlook http://www.reportlinker.com/p0558645...aign=Pathology Introduction This report covers the commercialization of stem cells (primarily derived from adult tissues) which are transplanted into patients to improve the function of diseased/damaged tissues/organs. Six indications are covered in detail. Sales forecasts are estimated in the US and five major European markets (5EU), which include France, Germany, Italy, Spain and the UK. Features and benefits * Identify potential growth markets with sales forecasts by indication and expected timing of market entry. * Compare the different business models for stem cell therapies. read... http://www.breitbart.com/article.php...show_article=1 |
|
|
|
|
06-21-2011, 09:38 PM
|
#4476 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Kurt May to Join International Stem Cell Corporation as Senior Vice President
© Business Wire 2011 2011-06-21 14:20:15 - Andrey Semechkin, Ph.D., CEO of International Stem Cell Corporation (OTCBB:ISCOE) (“ISCO”) announced today that Kurt May, a highly experienced senior business executive and biotechnology entrepreneur, is concluding his service as a faculty member at the University of San Diego’s School of Business Administration and is joining ISCO as a Senior Vice President. Mr. May’s duties will include mergers and acquisitions and development of new international collaborations, and he will work directly with Dr. Semechkin in implementing the Company’s business model of combining cutting-edge scientific research and building multiple revenue streams to support that research. read.... http://www.pr-inside.com/kurt-may-to...m-r2668447.htm |
|
|
|
|
06-21-2011, 09:42 PM
|
#4477 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
How stem cell treatment helped cure 10 years of pain caused by.. toothpaste
Jun 21 2011 By Samantha Booth JACQUELINE GEMMELL went into hiding after a bad reaction to toothpaste left her with a painful rash on her face. Steroid cream prescribed by the doctor only made it worse. When she tried a tiny amount on her face, it felt like tiny shards of glass as the lanolin in the cream burned her skin. But, thanks to a revolutionary stem-cell therapy, Jacqueline's face is finally back to normal after nearly eight years. The treatment has given her her life back. She said: "After it happened, I more or less went into hiding. I felt this hopelessness. read... http://www.dailyrecord.co.uk/life/wo...6908-23216564/ |
|
|
|
|
06-21-2011, 09:44 PM
|
#4478 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Device could improve harvest of stem cells from umbilical cord blood
Published: Monday, June 20, 2011 - 12:02 in Health & Medicine Johns Hopkins graduate students have invented a system to significantly boost the number of stem cells collected from a newborn's umbilical cord and placenta, so that many more patients with leukemia, lymphoma and other blood disorders can be treated with these valuable cells. The prototype is still in the testing stage, but initial results are promising. The student inventors have obtained a provisional patent covering the technology and have formed a company, TheraCord LLC, to further develop the technology, which may someday be used widely in hospital maternity units. The students say the need for this system is obvious. "Cord blood, collected from the umbilical cord and placenta after live birth, is the most viable source of stem cells, yet over 90 percent is uncollected and discarded," the team members wrote in a presentation of their project at the university's recent Biomedical Engineering Design Day. "One of the main reasons valuable cord blood is so frequently discarded is because no adequate collection method exists." The students say their easy-to-use invention, called the CBx System, could remedy these shortcomings. When a baby is born, a few families pay for private collection and storage of the child's cord blood, in case its stem cells are needed to treat a future illness. When families do not choose this option, the materials containing cord blood are generally thrown away as medical waste. But at the 180 hospitals affiliated with public cord blood banks, new mothers can donate cord blood so that its stem cells can be extracted and used to rebuild the immune systems of seriously ill patients, particularly those with blood cancers such as leukemia, lymphoma and myeloma. read... http://esciencenews.com/articles/201...s+-+Popular%29 |
|
|
|
|
06-22-2011, 10:07 AM
|
#4479 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Foundation hopes to raise $680,000 to purchase equipment for transplant procedure
A1 By Alyssa Mosher Times & Transcript Staff At 48, James Garland was diagnosed with multiple myeloma, a high-risk cancer that attacks the plasma cells in the bone marrow, the immune centre of the body. After his cancer was treated with regular chemotherapy, Garland's doctor told him he'd be a good candidate for stem cell therapy in Halifax. Garland said "sign me up." "I'm game for anything," he said. But travelling to Halifax from Grand Bay, outside of Saint John, wasn't an easy trek for Garland. He had lost 70 pounds by that point and was exhausted by the end of every trip, sometimes only for an hour-long consultation. After his stem cell transplant, not only had the travelling been hard on the body and mind, but it had also been hard on the pocket after loved ones chose to stay in Halifax for his recovery. read... http://www.canadaeast.com/rss/article/1417480 |
|
|
|
|
06-24-2011, 09:31 PM
|
#4480 |
|
Senior Member
Join Date: Nov 2004
Location: florida
Posts: 9,336
|
Singapore scientists discover how to control fate of stem cells
June 24, 2011 Scientists from the Genome Institute of Singapore (GIS), an institute of the Agency for Science, Technology and Research (A*STAR), in collaboration with the Cancer Science Institute of Singapore (CSI), have discovered how the body uses a single communication system to decide the fate of stem cells. The study, published in the scientific journal PLoS Genetics on 23rd June 2011, paves the way for the development of new methods of stem cell therapy with fewer side effects. Dr Kian Leong Lee and his team of scientists studied how a single signaling system known as the Nodal/Activin pathway tells stem cells what cell type they should eventually become. The pathway is able to specify a wide range of eventual cell types, challenging the current belief that chemical signaling systems are highly specific and only control a limited number of outcomes. This discovery is a major step forward for stem cell therapies and personalised medicine; by exploiting this signaling system, scientists will be able to control the eventual fate of a stem cell by simply adjusting the chemical environment of a cell. This method of controlling stem cell differentiation also avoids modifying the genetic material of the cell, a procedure that might lead to the cells becoming cancerous. read... http://www.physorg.com/news/2011-06-...tem-cells.html |
|
|
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Highlights and (My Reasons for) Hope from 2006 | Wise Young | Cure | 105 | 02-14-2007 09:32 AM |
| Announcement by NIH concerning stem cell sources | Wise Young | Cure | 3 | 06-27-2006 01:25 AM |
| Republican Senate Leader Frist to back ESC research! | Donny247 | Funding, Legislation, & Advocacy | 45 | 08-09-2005 08:00 AM |
| CAMR Calls for Bush's Help in Fully Implementing Stem Cell Policy | antiquity | Cure | 4 | 08-07-2002 11:30 AM |
Linear Mode
